Anaplastic thyroid carcinoma: palliation or treatment?
Authors:
- Richard O WeinRWRichard O Wein
- Randal S WeberRWRandal S Weber
- 1 April 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Otolaryngology & Head and Neck Surgery
- Vol. 19 (2) , 113-118
Abstract
To review the recent published literature on the topic of anaplastic thyroid carcinoma and discern if significant advances have occurred that alter the historically poor prognosis associated with this diagnosis. Surgical resection for patients with stage IVA disease (intra-thyroidal without extracapsular extension) with postoperative chemoradiation remains the standard recommendation. Care for patients with stage IVB disease, extrathyroidal spread without distant metastases, remains varied and controversial. Research into different molecular therapies (deacetylase inhibitors, tubulin binding compounds, etc.) and the pathogenesis of anaplastic carcinoma continues to evolve. Care for patients with metastatic disease, stage IVC, is focused on quality of life. Although occasional reports exist of long-term survivors with anaplastic thyroid carcinoma, the prognosis remains poor. Accurate staging is critical to offering the most appropriate treatment. Multimodality treatment is required if prolonged locoregional control or survival is desired.Keywords
This publication has 25 references indexed in Scilit:
- Detailed Molecular Fingerprinting of Four New Anaplastic Thyroid Carcinoma Cell Lines and Their Use for Verification of RhoB as a Molecular Therapeutic TargetThe Journal of Clinical Endocrinology & Metabolism, 2010
- Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging TherapiesClinical Oncology, 2010
- Lower Incidence of Anaplastic Carcinoma After Higher Iodination of Salt in SloveniaThyroid®, 2010
- Emerging molecular therapies of advanced thyroid cancerMolecular Aspects of Medicine, 2010
- Anaplastic Thyroid Cancer Manifesting as New-Onset Horner SyndromeEndocrine Practice, 2009
- Anaplastic Thyroid Carcinoma in a Young Woman: A Rare Case of SurvivalThyroid®, 2009
- Cutaneous Metastases in One of the Youngest Reported Patients with Anaplastic Thyroid CarcinomaThyroid®, 2009
- Multimodality treatment for anaplastic thyroid carcinoma – Treatment outcome in 75 patientsRadiotherapy and Oncology, 2009
- Hyperfractionated Accelerated Radiotherapy (HART) for Anaplastic Thyroid Carcinoma: Toxicity and Survival AnalysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Anaplastic Thyroid CancerEndocrinology and Metabolism Clinics of North America, 2008